Bovine pancreatic trypsin inhibitor (BPTI) is a protein of 58 amino acids. In its native state it has a well-defined tertiary structure stabilised by three disulfide bridges (
−S−) between cysteine residues at positions 5–55, 14–38, and 30–51, and it is a potent inhibitor of the enzyme trypsin.
A research team treats native BPTI with Compound X, which specifically reduces disulfide bridges to free thiol groups (
−SH). After treatment, trypsin-inhibitory activity falls to
5% of the original value. The treated BPTI is then allowed to refold in the presence of oxygen (which can re-oxidise thiol groups to disulfide bridges); after 24 hours, activity recovers to only
12% of the original value.
In a separate control experiment, native BPTI is denatured with
8M urea — which disrupts hydrogen bonds and hydrophobic interactions but leaves disulfide bridges intact — and then allowed to refold by dialysis to remove the urea. Activity recovers to
98% of the original value.